1. Home
  2. INV vs FDMT Comparison

INV vs FDMT Comparison

Compare INV & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INV
  • FDMT
  • Stock Information
  • Founded
  • INV 2015
  • FDMT 2013
  • Country
  • INV United States
  • FDMT United States
  • Employees
  • INV N/A
  • FDMT N/A
  • Industry
  • INV
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • INV
  • FDMT Health Care
  • Exchange
  • INV NYSE
  • FDMT Nasdaq
  • Market Cap
  • INV 676.8M
  • FDMT 420.7M
  • IPO Year
  • INV N/A
  • FDMT 2020
  • Fundamental
  • Price
  • INV $13.66
  • FDMT $6.31
  • Analyst Decision
  • INV
  • FDMT Buy
  • Analyst Count
  • INV 0
  • FDMT 11
  • Target Price
  • INV N/A
  • FDMT $42.80
  • AVG Volume (30 Days)
  • INV 141.8K
  • FDMT 1.0M
  • Earning Date
  • INV 02-15-2025
  • FDMT 11-13-2024
  • Dividend Yield
  • INV N/A
  • FDMT N/A
  • EPS Growth
  • INV N/A
  • FDMT N/A
  • EPS
  • INV N/A
  • FDMT N/A
  • Revenue
  • INV $988,000.00
  • FDMT $17,000.00
  • Revenue This Year
  • INV N/A
  • FDMT N/A
  • Revenue Next Year
  • INV N/A
  • FDMT $87.55
  • P/E Ratio
  • INV N/A
  • FDMT N/A
  • Revenue Growth
  • INV 4.88
  • FDMT N/A
  • 52 Week Low
  • INV $8.55
  • FDMT $5.58
  • 52 Week High
  • INV $18.75
  • FDMT $36.25
  • Technical
  • Relative Strength Index (RSI)
  • INV N/A
  • FDMT 36.69
  • Support Level
  • INV N/A
  • FDMT $5.58
  • Resistance Level
  • INV N/A
  • FDMT $7.58
  • Average True Range (ATR)
  • INV 0.00
  • FDMT 0.46
  • MACD
  • INV 0.00
  • FDMT -0.06
  • Stochastic Oscillator
  • INV 0.00
  • FDMT 34.93

About INV INNVENTURE INC

Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: